Research Article
Volume 7 Issue 3 - 2020
Role of APRI and FIB4 as a Non Invasive Tests for Assessment of Liver Fibrosis in Chronic HCV Infection
Mohamed Sayed1*, Mona amin2, May Fawzi2, Manal kamal3 and Samia Gabal4
1Assistant Professor of Internal Medicine, Cairo University, Egypt
2Professor of internal medicine, Cairo University, Egypt
3Professor of chemical pathology, Cairo University, Egypt
4Professor of pathology, Cairo University, Egypt
*Corresponding Author: Mohamed Hassan, Department of Gastroenterology, Cairo University, Egypt.
Received: May 15, 2019; Published: February 28, 2020




Abstract

Background: Liver biopsy is considered the reference method for assessing hepatic fibrosis in chronically infected hepatitis C virus (HCV) patients, but unfortunately has many complications.

Aim: This study aimed to assess the role of the aspartate aminotransferase-to-platelet ratio index (APRI) and fibrosis 4 (FIB-4) tests as non-invasive alternatives to liver biopsy.

Methods: Our study recruited 757 patients with a median age of 42.6 ± 10.3 years. All patients underwent liver biopsy for fibrosis stage estimation, and the APRI and FIB-4 tests were performed. The liver biopsies were scored using the METAVIR system: 13 patients were F0 (1.7%), 356 (47%) were F1, 227 (30%) were F2, 160 (21%) were F3, and 1 (0.1%) was F4.

Results. For predicting fibrosis stages F ≥ 3, APRI and FIB-4 had a specificity of 90% at cut-off values of 1.1 and 2.7, respectively and a specificity of 95% at cut-off values of 1.67 and 3.3 respectively. The area under the receiver operating characteristic curve (AUC) was 0.663 (95% confidence interval [CI], 0.617 - 0.709) for APRI and 0.673 (95% CI, 0.627 - 0.719) for FIB-4. For predicting F ≥ 2, APRI and FIB-4 had a specificity of 90% at cut-off values of 0.94 and 2.4 respectively, a specificity of 95% at cut-off values of 1.14 and 2.7 respectively. The AUC was 0.642 (95% CI, 0.603 - 0.681) for APRI and 0.676 (95% CI, 0.638 - 0.714) for FIB-4. 

Conclusion: For accurate non-invasive assessment of liver fibrosis stage, taking higher cut-off values for APRI and FIB-4 is recommended to improve their specificities.

Keywords: APRI; FIB4; Liver Fibrosis; HCV

References

  1. Doss W. “Egyptian National Control Strategy for Viral Hepatitis 2008-2012”. Arab Republic of Egypt: Ministry of Health and Population, National Committee for the Control of Viral Hepatitis (2008).
  2. H Kumada., et al. “Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection”. Hepatology 59 (2014): 2083-2091.
  3. James E., et al. “Prognostic Value of Ishak Fibrosis Stage: Findings from the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial”. Hepatology 51 (2010): 585-594.
  4. Ishak K., et al. “Histological grading and staging of chronic hepatitis”. Journal of Hepatology 22 (1995): 696-699.
  5. The French METAVIR Cooperative Study Group. “Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C”. Hepatology 20 (1994): 15-20.
  6. Afdhal NH and Nunes D. “Evaluation of liver fibrosis: a concise review”. American Journal of Gastroenterology 99 (2004): 1160-1174.
  7. Bedossa P., et al. “Sampling variability of liver fibrosis in chronic hepatitis C”. Hepatology 38 (2003): 1449-1457.
  8. Esmat, G., et al. “Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C”. Journal of Hepatology 46 (2007): 620-627.
  9. Guadalupe Garcia-Tsao., et al. “Prevention and Management of Gastroesophageal Varices and Variceal Hemorrhage in Cirrhosis”. Hepatology 46 (2007): 922-938.
  10. Bruix J and Sherman M. “Management of hepatocellular carcinoma: an update”. Hepatology 53 (2011): 1020-102. 
  11. Mitchell L Shiftman. “Fibrosis and Cirrhosis in HCV Infection”. Gastroenterol Hepatology 10 (2014): 43-45.
  12. European Association for the Study of the Liver. “EASL Clinical Practice Guidelines: management of hepatitis C virus infection”. Journal of Hepatology 55 (2011): 245-264.
  13. Ghany MG., et al. “American Association for the Study of Liver Diseases. Diagnosis, management, and treatment of hepatitis C: an update”. Hepatology 49 (2009): 1335-1374.
  14. Castera L. “Noninvasive methods to assess liver disease in patients with hepatitis B or C”. Gastroenterology 142 (2012): 1293-1302.
  15. Castera L and Pinzani M. “Biopsy and non invasive methods for the diagnosis of liver fibrosis: does it take two to tango?” Gut 59 (2010): 861-866. 
  16. Wai C-T., et al. “A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C”. Hepatology 38 (2003): 518-526.
  17. Lin Z-H., et al. “Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis”. Hepatology 53 (2011): 726-736. 
  18. Crisan D., et al. “Two or more synchro-nous combination of noninvasive tests to increase accuracy of liver fibrosis assessment in chronic hepatitis C results from a cohort of 446 patients”. Hepatitis Monthly 12 (2012): 177-184.
  19. Alboraie M., et al. “Value of Egy-Score in diagnosis of significant, advanced hepatic fibrosis and cirrhosis compared to aspartate aminotransferase-to-platelet ratio index, FIB-4 and Forns’ index in chronic hepatitis C virus”. Hepatology Research 45 (2015): 560-570.
  20. Holmberg SD., et al. “Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort”. Clinical Infection Diseases 57 (2013): 240-246.
  21. Vallet-Pichard A., et al. “FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest”. Hepatology 46 (2007): 32-36.
  22. Romanas Zykus., et al. “Combination of transient elastography with serum-based non-invasive tests improves prediction of liver fibrosis in patients with chronic hepatitis C: a prospective cohort study”. Acta Medica Lituanica 22 (2015): 77-84.
  23. Vallet-Pichard A., et al. “Fib-4: an inexpensive and accurate marker of fibrosis in HCV infection comparison with liver and fibrotest”. Hepatology 47 (2008): 762-763.
  24. Anaı¨sVallet-Pichard., et al. “FIB-4: an Inexpensive and Accurate Marker of Fibrosis in HCV Infection. Comparison with Liver Biopsy and FibroTest”. Hepatology 46 (2007): 32-36.
  25. Scott D Holmberg., et al. “Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort for the Chronic Hepatitis Cohort Study (CHeCS) Investigatorsa”. Clinical Infectious Diseases 57 (2013): 240-246.
  26. Chia-Chi Wang., et al. “Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients”. Journal of the Formosan Medical Association 114 (2015): 923-928.
  27. Lin ZH., et al. “Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis”. Hepatology 53 (2011): 726-736.
Citation: Mohamed Sayed., et al. “Role of APRI and FIB4 as a Non Invasive Tests for Assessment of Liver Fibrosis in Chronic HCV Infection”. EC Gastroenterology and Digestive System 7.3 (2020): 01-09.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.